Active Ingredient: Trimebutine, Simethicone
Dosage: 200 mg/75 mg
Route of Administration: Oral
Dosage Form: Tablets
Quantity per package: 24
Availability: Out of stock
Libertrim SII tablets are used to treat irritable bowel syndrome, acute and chronic colitis, spasmodic colitis, duodenitis and other pathologies. The drug is effective for the treatment of colic abdominal pain in case of constipation and/or diarrhea. In addition, it prevents and relieves flatulence, aerophagia, abdominal pain due to excess gas.
Libertrim SII is out of stock at the moment but you can find other options for treating gastrointestinal pathologies here.
These tablets, due to their content of trimebutine and simethicone, are indicated in the treatment of irritable bowel syndrome, acute and chronic colitis, spasmodic colitis, functional colopathies, duodenitis and other pathologies that present with tone alterations and gastroesophageal motility and intestinal as gastroesophageal reflux and esophagitis. It is effective and well-tolerated in the treatment of colic, abdominal pain in case of constipation and / or diarrhea. In addition, it prevents and relieves flatulence, aerophagia, abdominal pain due to excess gas.
Dosage and administration
For oral use.
- Adolescents: ½ tablet every 8 hours;
- Adults: 1 tablet every 8 or 12 hours.
It is recommended to take the medicine 15 to 30 minutes before meals, for at least 4 to 8 weeks, at the doctor’s discretion.
- Hypersensitivity to the active substances;
- Myasthenia gravis;
- Intestinal perforation.
In most cases, trimebutine, the active ingredient of Libertrim SII, has excellent tolerability. Only rarely have headaches or mild skin reactions been reported, which have not required suspension of treatment. Simethicone acts on the intestinal lumen so it is not absorbed. Trimebutin has a high clinical, blood and renal tolerability, which allows it to be used for a long time and that the doses are increased according to the requirements of the case and at the doctor’s discretion.
In case of poisoning due to overdose or accidental intake of Libertrim SII, gastric lavage, general measures and patient observation are recommended.
The reported studies and clinical experience with the use of trimebutine and simethicone show ample safety and tolerability. To date, there have been no reports of incompatibility in concomitant administration of the drug with antibiotics, antimicrobials, antiparasitic agents, NSAIDs, histamine H2 receptor antagonists, hypoglycemic agents, antihypertensives, benzodiazepines, among others.